{
    "organizations": [],
    "uuid": "be0a0b059d039a6e7f173dedf0c2d1dee3df2a65",
    "author": "",
    "url": "https://www.reuters.com/article/brief-seattle-genetics-commences-underwr/brief-seattle-genetics-commences-underwritten-public-offering-of-550-mln-of-shares-idUSASB0C36L",
    "ord_in_thread": 0,
    "title": "BRIEF-Seattle Genetics Commences Underwritten Public Offering Of $550 Mln Of Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 45 AM / in 11 minutes BRIEF-Seattle Genetics Commences Underwritten Public Offering Of $550 Mln Of Shares Reuters Staff \nJan 31 (Reuters) - Seattle Genetics Inc: \n* SEATTLE GENETICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK \n* SEATTLE GENETICS INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $550.0 MILLION OF SHARES OF ITS COMMON STOCK \n* SEATTLE GENETICS INC - ANTICIPATES USING NET PROCEEDS FROM OFFERING TO FUND A PORTION OF COSTS OF ACQUISITION OF CASCADIAN THERAPEUTICS  ",
    "published": "2018-01-31T13:44:00.000+02:00",
    "crawled": "2018-01-31T14:06:13.032+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "genetics",
        "commences",
        "underwritten",
        "public",
        "offering",
        "mln",
        "share",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "seattle",
        "genetics",
        "inc",
        "seattle",
        "genetics",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "seattle",
        "genetics",
        "inc",
        "commenced",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "seattle",
        "genetics",
        "inc",
        "anticipates",
        "using",
        "net",
        "proceeds",
        "offering",
        "fund",
        "portion",
        "cost",
        "acquisition",
        "cascadian",
        "therapeutic"
    ]
}